ADF Awards

The ADF announces various prizes to reward scientists / researchers from the field of dermatological research. In addition to the Paul Langerhans Award for established researchers and the Egon Macher Award for young investigators outstanding works in the field of allergy research (ADF / ECARF Award of European Allergy Research) and oncology (Dermato Oncology Junior Scientist Award) will be honored on the ADF Annual Meetings.

In addition, the best posters will be awarded with a poster prize.

For the complete tender texts and the detailed allocation policies please click on the highlighted link.

Please note:
For poster prices, the ADF / ECARF Award for European Allergy Research, the Dermato Oncology Junior Scientist Awards and for the Translational Research Award, a separate application is not necessary. For these prices all abstracts submitted before the deadline will be evaluated.
Submissions for the Paul Langerhans Award and the Egon Macher Award should be made in all cases exclusively in electronic form as one PDF file to the ADF office.
Submission deadline: November 01.

Back

ADF Poster Awards

At the ADF annual meeting several poster prizes (EUR 1000 each) will be awarded. The selection of awardees is carried out by an independent jury on each Annual ADF Meeting.

These poster prizes are donated by:

 

6 Poster awards by Almirall Hermal GmbH

2 Poster awards by Lilly Deutschland GmbH

Past awardees of the ADF Poster Awards

2024
Albert Koroma, Ulm
P038: Natural Killer Cells from Old Donors Fail to Efficiently Remove Senescent Fibroblasts from Aged Skin
2024
Viola DeTemple, Minden
P061: Effects of tirbanibulin on keratinocytes and squamous cell carcinoma cell lines in vitro
2024
Stefanie Schaerli, Bern
P105: IL-9 sensitizes human pathogenic Th2 cells to pro-inflammatory IL-18 signals in atopic dermatitis
2024
Katharina Hahn, Goettingen
P113: A Th2-Immunocompetent and Sensory Innervated Full-Thickness Skin Model for Neurocutaneous Inflammation in Atopic Dermatitis
2024
Jessica Eigemann, Munich
P138: VSNL1 – a novel factor in keratinocytes that promotes psoriatic skin inflammation
2024
Christine Zimmer, Marburg
P158: NK cells are activated and possess immunoregulatory functions in patients with pemphigus vulgaris
2024
Stefanie Kewitz-Hempel, Halle/Saale
P193: Melanoma cell-derived extracellular vesicles transport miR-92b-3p and mediates the formation of carcinoma-associated fibroblasts by targeting PTEN
2024
Antonia Stubenvoll, Leipzig
P196: Exploring primary malignant melanoma with single-cell multiomics: An investigation of cellular crosstalk and immune escape
2023
X. Luo, Berlin
P004: Mast cell-derived GM-CSF and physical interaction in the skin promotes bidirectional mast cell-eosinophil activation
2023
Jason Holsapple, Muenster
P011: Exploring Neutrophil Nuclear Dynamics and Neutrophil Extracellular Traps Using Expansion Microscopy
2023
Melike Sümbül, Kiel
P042: Dynamic Optical coherence tomography (D-OCT) of chronic inflammatory skin disease psoriasis vulgaris: advanced tool for treatment monitoring?
2023
Jule Focken, Tuebingen
P076: How neutrophils influence skin colonization and persistence of Staphylococcus aureus
2023
Susan Gellert, Magdeburg
P104: CD4+ effector T cells orchestrate indirect inflammatory killing of IFN-unresponsive tumors
2023
Hagen Lange, Magdeburg
P116: How skin inflammation shapes behavior ? role of the metabolite sensing Hca2/Gpr109a receptor
2023
Akiko Arakawa, München
P130: Gene flow from archaic hominins causes HLA-class I associated diseases, psoriasis, ankylosing spondylitis, and Behcet disease
2023
Saptaswa Dey, Graz
P169: Modified microbiota by skin disinfection through topical triple antibiotic treatment delays tumor growth and increases survival in a cutaneous T-cell lymphoma mouse model
2023
Sophie Dieckmann, Innsbruck
P184: Does aberrant glutamate metabolism in melanoma affect dendritic cell function?
2023
Johanna Strobl, Wien
P216: A specialized B cell-rich tumor microenvironment delineates cutaneous T cell lymphoma from benign inflammatory skin diseases
2022
Marlene Gottschalk, Bonn
P005: Anti CCL17/22 aptamers as possible therapeutic agents to suppress inflammation in contact hypersensitivity
2022
Philipp Haas, Ulm
P037: The Adaptive Response of Old ABCB5+ MSCs is Changed Upon Exposure to LPS
2022
Jan Niko Hartmann, Kiel
P055: Skin microbiome changes in atopic dermatitis patients under systemic treatment
2022
Lajos Kemény, Boston
P086: MC4R mediated melanocortin signaling antagonizes central endogenous opioid signaling to cause high pain thresholds in genetic mouse models of red hair
2022
Menatullah Mubarak, München
P096: The transcription factor CEBPB is a novel hub gene and multi-functional disease driver in skin inflammation
2022
Janne Ruotsalainen, Magdeburg
P098: Immunovirotherapy drives a convergent evolution towards interferon responsive, dedifferentiated cell states in cancer
2022
Alexandra Polakova, Marburg
P142: Diminished expression of tissue residency markers in skin lesions of patients with pemphigus vulgaris
2022
Lisa Kleissl, Wien
P160: Application of an inflammatory skin model with induced pluripotent stem cell-derived macrophages to study granuloma formation
2022
Johannes Hoffmann, Mannheim
P225: Hepatic steatosis and NASH-associated liver fibrosis promote adhesion and growth of melanoma cells in the hepatic vascular niche
2021
Philipp Esser, Freiburg
P011: Modulation of allergic contact dermatitis via unfolded protein response
2021
Kamveer Singh, Ulm
P025: Angiogenin Secreted from ABCB5+ MSCs Improves Healing of Diabetic Wounds by Promoting Angiogenesis
2021
Christian Posch, München
P048: Adjuvant melanoma treatment: real-world data from the DACH region
2021
Mingfeng Li, Freiburg
P088: A novel NLRP1 mutation causes different phenotypes in siblings
2021
Anaïs Doll, Munich
P121: Low invasive microbiopsies are sufficient to perform immune-based molecular classification of inflammatory skin diseases.
2021
A. Seretis, Innsbruck
P126: Development of combination therapy to delay resistance in BRAF-inhibitor treated melanoma
2021
Barbara Meier-Schiesser, Zurich
P144: Acute Generalized Exanthematous Pustulosis ? Not only a T cell Driven Disease? Impact of Innate Immunity in Adverse Drug Reactions of the Skin
2021
Sabine Ring, Heidelberg
P155: Regulatory T cells prevent neutrophilic infiltration of skin during contact hypersensitivity reactions by strengthening the endothelial barrier
2021
Martin Metz, Berlin
P179: Development and validation of the Prurigo Control Test (PCT) ? A patient reported outcome measure to assess disease control in chronic prurigo
2021
Miriam Mengoni, Magdeburg
P218: The aryl hydrocarbon receptor differentially modulates inflammatory responses in human and mouse melanoma cell lines
2021
Jana Liebing, Bonn
P222: Influence of the Fatty Acid Composition of the Tumor Microenvironment on Melanoma Phenotype
2020
No Awards
2019
Patricia Rostan, Mainz
P005: Human IL-10 DC facilitate cross-tolerance in birch pollen allergic patients with associated food allergy in vitro and in vivo
2019
Janina Trothe, Frankfurt
P026: Function of LRRC8 volume-regulated anion channels during hypotonic stress response and differentiation of human keratinocytes
2019
Nikolaus Wagner, Tübingen
P057: Occurrence of autoimmune thyroiditis predicts response and favorable progression-free survival of melanoma patients receiving PD-1 antibodies
2019
Rosi Wang, München
P061: CD23 is a biomarker of clinical response to IgE-specific immunoadsorption in patients with severe atopic eczema
2019
Dora Stoelzl, Kiel
P088: Treatment of moderate-to-severe atopic dermatitis (AD) after the approval of the first biologic agent: results from the german national registry TREATgermany
2019
Naveen Shridhar, Magdeburg
P113: Development of antigen specific immunotherapy against melanoma with TRP1 targeted CD4+ T cell transfer.
2019
Tanya Sezin, Lübeck
P129: The Ornithodoros moubata soft-tick-derived lipocalin Coversin abrogates skin inflammation in a murine model of pemphigoid diseases by sequestering complement factor C5 and leukotriene B4
2019
Nicole Glodde, Bonn
P145: CRISPitope: A Versatile Approach To Study How The Target Antigen Choice Influences Antigen-Specific T-cell Therapy
2019
Christoph Hudemann, Marburg
P155: Detection of low-frequent desmoglein 3-specific T and B cells in an HLA-transgenic mouse model of pemphigus vulgaris
2019
Andreas Recke, Lübeck
P158: Identification of the mutation c.9886A>G, p.Lys330Glu in the plasminogen gene in a family from Northern Germany with hereditary angioedema
2019
Kondaiah Moganti, Münster
P169: Cutaneous over-expression of RANKL leads to suppression of anti-microbial immune responses
2019
Barbara Schuster, München
P184: Medical needs related to pruritus in Germany - a 2-year Google search engine analysis
2018
Katharina Bitschar, Tübingen
S. epidermidis-induced reduction of S. aureus skin colonization depends on the activation of Interleukin-1 receptor-induced innate immune signaling pathways
2018
Christine Consentius, Berlin
Think big and scale down: development of a multi-organ-on-the-chip-model for analysis of immune cell - skin interactions
2018
Georg Daeschlein, Greifswald
Hyperspektral-Imaging als Neues Verfahren in der Wunddiagnostik
2018
Juliana de Castro Kroner, Köln
Glucocorticoids promote intrinsic human Th17 differentiation
2018
Stefanie Hoyer, Erlangen
BRAF and MEK inhibitors change human immune cell phenotype and function possible consequences for combination therapy
2018
Victoria Lang, Frankfurt
Aberrant mTORC1 activity induces Stat3 and contributes to the psoriatic differentiation defect
2018
Diego Martin-Garcia, Heidelberg
Role of CC-chemokine Receptor 6 (CCR6) and CC-chemokine Ligand 20 (CCL20) mediated immunosurveillance in malignant melanoma
2018
Elisabeth Roider, Zürich
Intracellular redox changes alter tyrosinase protein stability and enable UV- and MITF-independent skin color change
2018
Janne Ruotsalainen, Magdeburg
Type I IFN responsiveness of melanoma is cell state dependent and can be both harnessed and suppressed to enhance oncolytic virotherapy efficacy
2018
Maria Isabel Schmidgen, Mainz
Tissue factor-PAR2 signaling mediates inflammation in contact hypersensitivity
2018
Agnetha Schulz, Lübeck
Active recruitment of mast cells to the microenvironment of malignant melanoma
2018
Elina Stoffel, Tübingen
Analysis of anti-TNF-induced skin lesions reveals strong Th1 activation with some distinct immunological characteristics
2017
Christian Adam, Würzburg
Potent NLRP3 inflammasome activation by the allergy-inducing HIV reverse-transcriptase inhibitor abacavir
2017
Benedikt Herold/Juliane de Vries, Ulm
Osteopontin as a potential regulator of dermal ABCB5+ MSC maintenance
2017
A. Kwaczala-Tessmann
Cytoskeletal reorganization during NET formation
2017
David Rafei-Shamsabadi, Freiburg
Type 2 innate lymphoid cells act as regulators of type I driven TNCB contact hypersensitivity
2017
E. Rodríguez, Kiel
Global RNA expression profiling in skin provides insights into disease mechanisms of atopic eczema and psoriasis
2017
Franziska Krebs, Mainz
Investigating immunosuppressive regulatory T cells (Treg) and myeloid-derived suppressor cells (MDSC) in checkpoint inhibitor therapy of malignant melanoma
2016
Vida Farsam, Ulm
Senescent fibroblasts enhance cutaneous squamous cell carcinoma progression through secretion of Chemerin and activation of MAPK pathway
2016
Christine Hosp, Würzburg
Successful immunotherapy in a new mouse model of wasp venom allergy
2016
Jana Knuever, Cologne
Myeloid cell-restricted Insulin/IGF-1 signaling controls cutaneous inflammation
2016
Corinna Kosnopfel, Tuebingen
In and outside the melanoma cell: The Y-box binding protein 1 as a novel tumour marker and therapeutic target in vemurafenib resistance
2016
Maria Schmidgen, Mainz
Role of protease-activated receptor 2- and tissue factor-mediated signaling in contact hypersensitivity
2016
Emmi Wachsmuth, Cologne
Map kinase p38alpha stress signaling repairs skin barrier defects caused by loss of insulin/IGF-1 signaling
2015
Andrea Braun, Goettingen
Integrin αE(CD103) - a modulator of regulatory T cell function in allergic contact hypersensitivity
2015
Timo Buhl, Goettingen
Epidermal PAR2 overexpression causes atopic dermatitis-like skin disease: Neuro-epidermal communication
2015
Claudia Guenther, Dresden
Defective removal of ribonucleotides from DNA promotes systemic lupus erythematosus
2015
Elena Makino, Tuebingen
The role of beta-catenin in the therapy resistance of malignant melanoma to BRAF inhibitors
2015
Kathrin Tarnanidis, Heidelberg
RAGE signaling drives the initiation and maintenance of the psoriatic inflammation
2015
Susanne Vorhagen, Cologne
Unraveling the role of aPKCλ in the regulation of oriented cell division and stem cell homeostasis in the mammalian epidermis
2014
S. A. Graf, München
The role of SOX10 in melanoma cell invasion
2014
S. Kaesler, Tübingen
TLR2-ligands promote chronic atopic dermatitis inflammation based on IL-4-mediated suppression of IL-10
2014
B. Kraft, Tübingen
Immune conditioning of the epithelial surface by skin microbiota enhances innate immune response towards pathogens
2014
M. Rogava, Bonn
Sensing of UVB-induced DNA damage in the skin by the innate immune system involves the TLR4- and MyD88-dependent signaling pathway.
2014
M. Rübsam, Köln
Classical cadherins control epidermal barrier function: regulation through actomyosin?
2014
D. Terhorst, Berlin
Laser-assisted intradermal delivery of Xcl1-specific fusion vaccines induces potent anti-tumor response
2013
K. Satoh, Mainz
Kinome profiling of human regulatory T cells reveals novel target structures to modify their functional activity
2013
Y. Qi, Ulm
Phenotypic Switching from M1 to M2 Macrophages by Mesenchymal Stem Cells Improves Wound Healing in an Iron-Overload Mouse Model
2013
A. Hossini, Dessau
Induced pluripotent stem cell-derived neurons from a sporadic Alzheimer's disease donor as a model for investigating disease mechanisms
2013
S. Käsler, Tübingen
Mast cells establish effective anti-tumor immune defense
2013
Y. Skabytska, Tübingen
Post-septic immune-suppression following Gram positive sepsis is mediated by TLR dependent induction of myeloid derived suppressor cells.
2013
T. Bald, Bonn
TLR4-dependent inflammation in the tumor microenvironment expands myeloid-derived suppressor cells that promote metastatic progression of melanoma in the Hgf-Cdk4 mouse model
2012
Stephanie Traub, Köln
Agonistic VEGF-variants engineered to simultaneously bind to and stimulate VEGFR-2 and alphaVbeta3 integrin
2012
L. Froesewitte, Kiel
Is Loricrin a trojan horse antimicrobial peptide mimicking a bacterial microcin B17 precursor?
2012
D. Beck, Tübingen
The BRAFV600E kinase inhibitor vemurafenib induces apoptosis through a process involving induction of endoplasmic reticulum stress in melanoma cells
2012
Maria Gaiser, Bethesda/Heidelberg
Langerhans cell-selective deletion of EpCAM (CD326) attenuates Langerhans cell motility and migration in vivo and enhances contact hypersensitivity reactions
2012
Anja Rabenhorst, Köln
Mast cells play a protumorigenic role in primary cutaneous lymphoma
2012
E. Doyle, Berlin
Tryptase therapy counteracts lethal effects of snake venom: a new treatment for snakebite
2011
A. Schlecht, Ulm
Beta2 integrin-dependent release of oxygen radicals from macrophages is required for TGF-beta1 activation in cutaneous wound repair
2011
Astrid Schmieder, Mannheim
Pro- and anti-inflammatory signalling cascades synergize to induce an M2-like tumor macrophage-associated activation pathway involving the novel CD20 homolog Ms4a8a
2011
Stefanie Hoyer, Erlangen
Providing T-cell help to dendritic cells to induce better anti-tumor immune responses
2011
Christian Hafner, Regensburg
Multiple oncogenic mutations and clonal relationship in spatially distinct benign human epidermal tumors
2011
Ilknur Senyürek, Tübingen
Extracellular matrix components in skin barrier function
2011
Carina Hillgruber, Münster
Von Willebrand factor promotes cutaneous inflammation
2010
Christoffer Gebhardt, Heidelberg
Endothelial cell-specific functions of RAGE signaling in inflammation and cancer
2010
Florian Woelbing, Tübingen
Dissecting early and late phase mast cell activation pathways: Serum- and glucocorticoid-inducible kinase 1 is critical for early but dispensable for delayed type mast cell responses
2010
Lena Hardkop, Lübeck
The dermato-endocrine regulator melatonin modifies the time- and dose-dependent UV-response in a human full skin model in vitro
2010
Christian Hofmann, Erlangen
TCR-RNA-reprogrammed T cells are able to recognize HIV-epitopes
2010
Angela Nagel, Marburg
The clinical activity of pemphigus vulgaris is directly linked to IgE autoantibodies reactive with desmoglein 3
2010
Jennifer Landsberg, Bonn
Neonatal UV irradiation promotes multistage melanomagenesis in the Hgf-Cdk4R24C C57BL/6 mouse tumor model